Common Stock, Shares, Issued of Immunovant, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Immunovant, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Immunovant, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 203,316,885, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 203,316,885 +56,113,320 +38% 31 Dec 2025 10-Q 06 Feb 2026 2026 Q3
Q3 2025 174,532,710 +27,967,661 +19% 30 Sep 2025 10-Q 10 Nov 2025 2026 Q2
Q2 2025 171,069,176 +24,873,503 +17% 30 Jun 2025 10-Q 11 Aug 2025 2026 Q1
Q1 2025 170,111,593 +24,528,594 +17% 31 Mar 2025 10-Q 06 Feb 2026 2026 Q3
Q4 2024 147,203,565 +2,109,513 +1.5% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 146,565,049 +15,123,025 +12% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 146,195,673 +15,630,244 +12% 30 Jun 2024 10-Q 06 Aug 2024 2025 Q1
Q1 2024 145,582,999 +15,253,136 +12% 31 Mar 2024 10-K 29 May 2025 2025 FY
Q4 2023 145,094,052 +15,833,798 +12% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q3
Q3 2023 131,442,024 +14,827,936 +13% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 130,565,429 +14,041,271 +12% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 130,329,863 +13,846,964 +12% 31 Mar 2023 10-K 29 May 2024 2024 FY
Q4 2022 129,260,254 +14,150,421 +12% 31 Dec 2022 10-Q 03 Feb 2023 2023 Q3
Q3 2022 116,614,088 +1,615,217 +1.4% 30 Sep 2022 10-Q 04 Nov 2022 2023 Q2
Q2 2022 116,524,158 +18,546,563 +19% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 116,482,899 +18,511,656 +19% 31 Mar 2022 10-K 22 May 2023 2023 FY
Q4 2021 115,109,833 +17,138,590 +17% 31 Dec 2021 10-Q 04 Feb 2022 2022 Q3
Q3 2021 114,998,871 +17,108,166 +17% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q2
Q2 2021 97,977,595 +16,165,868 +20% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q1
Q1 2021 97,971,243 +41,515,867 +74% 31 Mar 2021 10-K 08 Jun 2022 2022 FY
Q4 2020 97,971,243 +41,515,867 +74% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 97,890,705 +94,358,157 +2671% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 81,811,727 +78,266,670 +2208% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
Q1 2020 56,455,376 +17,864,995 +46% 31 Mar 2020 10-K 01 Jun 2021 2020 FY
Q4 2019 56,455,376 +53,580,376 +1864% 31 Dec 2019 10-Q 14 Feb 2020 2019 Q3
Q3 2019 3,532,548 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 3,545,057 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 38,590,381 31 Mar 2019 10-K 29 Jun 2020 2019 FY
Q4 2018 2,875,000 31 Dec 2018 10-Q 13 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.